Cyclogest
Phase 1Small molecule
Cyclogest is one of 8 small molecule programs targeting Progesterone. It is currently in Phase 1.
1
Indications
1
Total Trials
1
Active Trials
7
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
7 competitors in Progesterone
#DrugCompanyPhaseTrials
1Prometrium
FerringApproved
Micronized Progesterone
AAdvancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
Phase 3
Activella
Eli LillyPreclinical
Ulipristal Acetate
AbbViePreclinical
Cyclogest
CCalla Lily Clinical Care Ltd
Phase 1
Prometrium
SSolvay Pharmaceuticals
Preclinical
Estrace
UUniversity of Virginia
Preclinical
Dydrogesterone Pill
NNational University of Malaysia
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Cyclogest. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Phase 1[1]
- Company
- CCalla Lily Clinical Care Ltd